The Q2 earnings are largely irrelevant to the stock's trajectory; the sole catalyst is the pending Noble Africa reverse merger expected in Q4 2026. Traders should monitor stockholder vote and regulatory approvals for the merger, as well as the concurrent $50M private placement, which will determine the combined entity's valuation and liquidity post-close.
Price Chart
Executive Summary
ENDRA Life Sciences reported Q2 2026 net income of ~$160,000, a significant swing from a $1.2M net loss in Q2 2025, driven by $1.6M in digital asset gains. However, the core business remains pre-revenue with an operating loss of $1.48M, and the stock's value is now tied entirely to the pending reverse merger with Noble Africa, which is expected to close in Q4 2026. The EPS of ~$0.11 (based on ~1.5M shares) represents a beat vs the $-0.84 consensus, but this is a mechanical artifact of non-operating digital asset gains on a tiny share count, not a fundamental improvement.
Key Financial Metrics
Key Facts
- Reported net income of ~$160,000 for Q2 2026 vs a net loss of ~$1.2M in Q2 2025, driven by $1.6M in realized/unrealized digital asset gains.
- Core operating loss widened to $1.48M from $1.30M YoY, with operating expenses increasing due to $542k in non-cash stock-based compensation.
- Cash used in operations improved to ~$0.9M from ~$1.1M YoY.
- Cash and restricted cash totaled $5.5M as of June 30, 2026, including $3.8M from a May 2026 private placement.
- On June 25, 2026, ENDRA entered a definitive merger agreement with Noble Africa LLC; upon closing, ENDRA will be renamed Noble Africa Inc. and stockholders will gain exposure to Renergen's Virginia Gas Project.
- The merger is expected to close in Q4 2026, subject to stockholder and regulatory approvals, with a concurrent $50M private placement.
- EPS of ~$0.11 (based on ~1.5M shares) vs consensus of $-0.84 is a mechanical beat driven by non-operating digital asset gains and a low share count, not a fundamental earnings improvement.
Financial Impact
Net income of ~$160k vs net loss of ~$1.2M YoY; operating loss of ~$1.5M; cash burn ~$0.9M/quarter; $5.5M total cash (incl. restricted) provides runway through expected Q4 2026 merger close.
Risk Factors
- Merger fails to close (stockholder or regulatory rejection), leaving ENDRA as a pre-revenue cash-burning shell with ~$5.5M cash.
- Dilution from the $50M private placement and share issuance in the merger could pressure post-close stock price.
- Nasdaq delisting risk if the merger is delayed or fails, given the company's low market cap and cash position.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-090747 |
| Document: ea0302156-8k425_endra.htm | 0001213900-26-090747 |
| Document: 0001213900-26-090747-index-headers.html | 0001213900-26-090747 |
| Document: 0001213900-26-090747-index.html | 0001213900-26-090747 |
| Document: 0001213900-26-090747.txt | 0001213900-26-090747 |
| 8-K Data (Synthetic) | 0001213900-26-090747 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 425 | $4.82 | awaiting T+5 | — | $4.96 (+2.93%) |
Oct 8, 2026 19d ago | 3 | $5.46 $4.74 | ▼ −13.19% | ▼ −11.22% | $4.96 (−9.14%) |
Oct 8, 2026 19d ago | SC 13D | $5.46 $4.74 | ▼ −13.19% | ▼ −11.22% | $4.96 (−9.14%) |
Oct 1, 2026 26d ago | 425 | $6.06 $5.46 | ▼ −9.90% | ▼ −11.06% | $4.96 (−18.14%) |
Oct 1, 2026 26d ago | 8-K | $6.06 $5.46 | ▼ −9.90% | ▼ −11.06% | $4.96 (−18.14%) |
Sep 25, 2026 4w ago | 425 | $5.80 $6.31 | ▲ +8.79% | ▲ +7.59% | $4.96 (−14.47%) |
Sep 9, 2026 6w ago | 425 | $5.83 $5.13 | ▼ −12.01% | ▼ −11.67% | $4.96 (−14.91%) |
Aug 17, 2026 10w ago | 8-K | $4.51 $4.75 | ▲ +5.32% | ▲ +5.52% | $4.96 (+10.00%) |
Jul 17, 2026 14w ago | 425 | $4.99 $5.23 | ▲ +4.81% | ▲ +5.50% | $4.96 (−0.58%) |
Jul 9, 2026 15w ago | 8-K | $5.49 $5.27 | ▼ −4.01% | ▼ −3.88% | $4.96 (−9.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers